FABP4 and diabetes mellitus: Fourth, some diabetes markers, such as Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and Hemoglobin A1c (HbA1c) might affect the predictive effectiveness of FABP4 in the non-diabetic patients.